Biomoneta’s Historic FDA Nod: How an Indian Startup is Conquering the Global Airborne Pathogen Battle
In a landmark achievement for Indian healthtech and deep-science innovation, Bengaluru-based Biomoneta Research Private Limited has become the first Indian healthtech startup to secure US FDA 510(k) Class II clearance. This prestigious regulatory milestone is for its flagship product, the Avata Rx Medical Recirculating Air Cleaner—a device powered by the company’s globally patented ZeBox® technology, which has demonstrated the ability to destroy airborne pathogens with over 99.9% efficacy.






